Original Article
Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors
Linda E. Lévesque, James M. Brophy and Bin Zhang
CMAJ May 02, 2006 DOI: https://doi.org/10.1503/cmaj.051679
Linda E. Lévesque
James M. Brophy
In this issue
Article tools
Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors
Linda E. Lévesque, James M. Brophy, Bin Zhang
CMAJ May 2006, DOI: 10.1503/cmaj.051679
Related Articles
Cited By...
- COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells
- Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction: A Nationwide Cohort Study
- Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
- Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding
- Cardiac risks with COX-2 inhibitors
- Celecoxib Prevents Neuroblastoma Tumor Development and Potentiates the Effect of Chemotherapeutic Drugs In vitro and In vivo
- Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs.
- Balancing the cyclooxygenase portfolio.